Organogenesis Holdings Inc stock is traded at $0.8399, with a volume of 708,846. It is down -3.46% in the last 24 hours and down -34.89% over the past month. Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Previous Close:
$0.87
Open:
$0.897
24h Volume:
708,846
Relative Volume:
0.57
Market Cap:
$108.07M
Revenue:
$514.70M
Net Income/Loss:
$2.72M
P/E Ratio:
-
EPS:
-$0.1589
Net Cash Flow:
$17.08M
1W Performance:
+2.56%
1M Performance:
-34.89%
6M Performance:
-67.57%
1Y Performance:
-78.84%
1-Day Range:
$0.8$0.9
1-Week Range:
$0.73$0.91
52-Week Range:
$0.73$7.08
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS